CHM 0.00% 1.4¢ chimeric therapeutics limited

It appears that CHM's preclinical results are on-par, if not...

  1. 7,969 Posts.
    lightbulb Created with Sketch. 3412
    It appears that CHM's preclinical results are on-par, if not superior, to those of Satri-cel (using the same source of reference) which align with CHM reports:

    https://hotcopper.com.au/data/attachments/6462/6462510-705589c51a520aaababab8b18db78f17.jpg
    https://hotcopper.com.au/data/attachments/6462/6462516-95c0b7956c80fb58bf76cefe7eb67222.jpg
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.